(Q67690155)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1709827%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1709827%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

main subject

lymphocyte activation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709827

4 November 2022

immunologic cytotoxicity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709827

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

4 November 2022

author name string

H. Rabinowich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709827

4 November 2022

P. Sedlmayr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709827

4 November 2022

R. B. Herberman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709827

4 November 2022

T. L. Whiteside

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709827

4 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1709827

4 November 2022

publication date

1 July 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1709827%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

number of pages

17

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:000887499190290R?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

https://api.elsevier.com/content/article/PII:000887499190290R?httpAccept=text/plain

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

4 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1709827%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1709827%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1709827%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

454-470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1709827%20AND%20SRC:MED&resulttype=core&format=json

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen

4 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Lymphokine-activated killer cells. Analysis of progenitors and effectors

4 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

4 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells

4 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells

4 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

4 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

A clonal analysis of human peripheral blood lymphocytes displaying natural killer-like activity

4 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Characteristics and mechanisms of action of the concanavalin A-activated suppressor cell in man

4 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

4 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Unimpaired ability to generate adherent lymphokine-activated killer (A-LAK) cells in patients with primary or metastatic liver tumors

4 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

4 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens

4 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

4 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90290-R

4 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1709827%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference